JHTV/FastForward, 1812 Ashland Ave.
Transform your early-stage development. This lunch and learn covers selecting oral formulations for small molecules in preclinical/ early-phase studies with Developability Classification System (DCS), amorphous solid dispersions, lipid-based strategies, and PBPK-guided decisions. Gain actionable steps to improve translational success and speed first-in-human readiness.
EVENT DETAILS
- Nov. 11 | 11 a.m.-1 p.m.
- JHTV Innovation Hub
1812 Ashland Avenue, Suite 110
Baltimore, MD 21205 - Lunch will be provided
SPEAKER
Brent Moody
Calatent
Director, Scientific Advisory Services
With over 28 years of industry experience in drug delivery, drug product development, and GMP manufacturing operations, Brent’s expertise spans from oral and injectable formulation development to laboratory leadership.